| Cost-effectiveness of a hypothetical cell or gene therapy cure for sickle cell disease J Salcedo, J Bulovic, CM Young Scientific Reports 11 (1), 10838, 2021 | 21 | 2021 |
| A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma J Lam, JW Hay, J Salcedo, NJ Kenyon Journal of Asthma 56 (8), 872-881, 2019 | 21 | 2019 |
| Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function J Salcedo, JW Hay, J Lam International journal of cardiology, 2018 | 17 | 2018 |
| Cost-Effectiveness Of Rivaroxaban Versus Warfarin For Treatment Of Nonvalvular Atrial Fibrillation In Patients With Worsening Renal Function J Salcedo, JW Hay, J Lam Value in Health 21, S61, 2018 | 17 | 2018 |
| Cost-effectiveness analysis of robotic-arm assisted total knee arthroplasty Y Hua, J Salcedo PLOS ONE 17 (11), e0277980, 2022 | 14 | 2022 |
| Cost-effectiveness of artificial intelligence monitoring for active tuberculosis treatment: A modeling study J Salcedo, M Rosales, JS Kim, D Nuno, S Suen, AH Chang PloS one 16 (7), e0254950, 2021 | 13 | 2021 |
| Cost‐effectiveness of chemoradiation followed by esophagectomy versus chemoradiation alone in squamous cell carcinoma of the esophagus J Salcedo, S Suen, SX Bian Cancer Medicine 9 (2), 440-446, 2020 | 6 | 2020 |
| The total direct cost of healthcare in the United States in patients with sickle cell disease: a propensity score matched analysis J Salcedo, CM Young, J Bulovic Blood 134, 4671, 2019 | 5 | 2019 |
| S836 Health-Related Quality of Life of Week 8 Responders and Non-Responders: Results from the RBX2660 Phase 3 Randomized, Placebo-Controlled Trial in Recurrent Clostridioides … P Feuerstadt, ER Dubberke, A Guo, A Harvey, M Yang, V Garcia-Horton, ... The American Journal of Gastroenterology 117 (10S), e604-e605, 2022 | 2 | 2022 |
| PIN23 Cost-effectiveness evaluation of artificial intelligence monitoring of active tuberculosis treatment in los angeles county, california: a pilot study J Salcedo, M Rosales, D Nuno, SC Suen, AH Chang Value in Health 22, S198, 2019 | 2 | 2019 |
| Cost-Effectiveness of Novel Artificial Intelligence Platform Aicure for Active Tuberculosis Treatment in Los Angeles County J Salcedo, M Rosales, D Nuno, SC Suen, AH Chang Medical Decision Making 39 (1), E14-E15, 2018 | 2 | 2018 |
| S838 Health-Related Quality of Life in Patients With One Prior Episode of Recurrent Clostridioides difficile Infection (rCDI): Results from the RBX2660 Phase 3 Randomized … P Feuerstadt, ER Dubberke, A Guo, A Harvey, M Yang, V Garcia-Horton, ... The American Journal of Gastroenterology 117 (10S), e606, 2022 | 1 | 2022 |
| An evaluation of the cost-effectiveness of reslizumab in poorly controlled eosinophilic asthma J Lam, JW Hay, J Salcedo, NJ Kenyon Value in Health 21, S235, 2018 | 1 | 2018 |
| EE194 Modelling Long-Term Clinical Outcomes of Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in the United States J Wang, C Udeze, FJ Ogunsile, Y Xie, U Mujumdar, H Yang, J Salcedo, ... Value in Health 25 (12), S91, 2022 | | 2022 |
| Cost-Effectiveness Analysis of Robotic-Arm Assisted Total Knee Arthroplasty Y Hua, J Salcedo Medical Decision Making 42 (4), NP9-NP10, 2022 | | 2022 |
| Essays in Health Economics J Salcedo University of Southern California, 2020 | | 2020 |
| Pediatric Inpatient Costs of Select Orphan Conditions with Potential Gene Therapy Launches: A Cross-Sectional Analysis of 2016 J Salcedo, J Bulovic, R Shinkle, S Trieu Journal of Managed Care and Specialty Pharmacy 25 (10-a Suppl), S89, 2019 | | 2019 |
| Artificial intelligence monitoring of active TB cost effective J Salcedo PharmacoEconomics & Outcomes News 830, 3-15, 2019 | | 2019 |
| PIH27 THE CASE FOR THE INCLUSION OF HUMAN MILK INTO GEORGIA STATE'S MEDICAID REIMBURSEMENT STRUCTURE: A BUDGET IMPACT ANALYSIS J Salcedo, C Schmaltz, J Hay, L Summers Value in Health 22, S187, 2019 | | 2019 |
| PCN126 LIFETIME COSTS FOR DIFFUSE LARGE B-CELL LYMPHOMA AND B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A LITERATURE REVIEW TO INFORM POTENTIAL FINANCIAL IMPACT OF CURATIVE THERAPIES J Salcedo, CM Young Value in Health 22, S79-S80, 2019 | | 2019 |
Joel HayProfessor of Health Economics, University of Southern CaliforniaVerified email at usc.edu
